Nektar Therapeutics (NKTR)
37.92
-1.92
(-4.82%)
USD |
NASDAQ |
Oct 13, 16:00
37.96
+0.04
(+0.11%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (TTM) : -6.697 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.697 |
| March 31, 2026 | -8.420 |
| December 31, 2025 | -6.846 |
| September 30, 2025 | -4.559 |
| June 30, 2025 | -2.861 |
| March 31, 2025 | -0.1591 |
| December 31, 2024 | -0.1069 |
| September 30, 2024 | -0.8371 |
| June 30, 2024 | -0.9007 |
| March 31, 2024 | -0.9196 |
| December 31, 2023 | -1.456 |
| September 30, 2023 | -1.553 |
| June 30, 2023 | -1.627 |
| March 31, 2023 | -2.209 |
| December 31, 2022 | -1.970 |
| September 30, 2022 | -2.44 |
| June 30, 2022 | -2.830 |
| March 31, 2022 | -2.665 |
| December 31, 2021 | -2.857 |
| September 30, 2021 | -2.722 |
| June 30, 2021 | -2.624 |
| March 31, 2021 | -2.385 |
| December 31, 2020 | -2.490 |
| September 30, 2020 | -2.474 |
| June 30, 2020 | -10.30 |
| Date | Value |
|---|---|
| March 31, 2020 | -19.33 |
| December 31, 2019 | -28.87 |
| September 30, 2019 | -28.80 |
| June 30, 2019 | -20.92 |
| March 31, 2019 | -6.116 |
| December 31, 2018 | 3.610 |
| September 30, 2018 | 3.964 |
| June 30, 2018 | 4.894 |
| March 31, 2018 | -0.8201 |
| December 31, 2017 | -0.6403 |
| September 30, 2017 | -0.7098 |
| June 30, 2017 | -1.399 |
| March 31, 2017 | -1.370 |
| December 31, 2016 | -1.098 |
| September 30, 2016 | -1.219 |
| June 30, 2016 | -0.9654 |
| March 31, 2016 | -1.009 |
| December 31, 2015 | -0.616 |
| September 30, 2015 | -0.5657 |
| June 30, 2015 | 0.0303 |
| March 31, 2015 | 0.1734 |
| December 31, 2014 | -0.4499 |
| September 30, 2014 | -0.5066 |
| June 30, 2014 | -1.184 |
| March 31, 2014 | -1.297 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Eli Lilly & Co. | 29.43 |
| Inovio Pharmaceuticals, Inc. | -1.176 |
| Tonix Pharmaceuticals Holding Corp. | -12.93 |
| Capricor Therapeutics, Inc. | -2.449 |
| Kyntra Bio, Inc. | 32.31 |